Page last updated: 2024-08-21

arsenic trioxide and metoprolol

arsenic trioxide has been researched along with metoprolol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ducas, J; Ducas, RA; Seftel, MD; Seifer, C	1

Reviews

1 review(s) available for arsenic trioxide and metoprolol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

1 other study(ies) available for arsenic trioxide and metoprolol

Article	Year
Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia. The journal of the Royal College of Physicians of Edinburgh, 2011, Volume: 41, Issue:2 Topics: Adult; Anti-Arrhythmia Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Electrocardiography; Female; Humans; Leukemia, Promyelocytic, Acute; Magnesium; Manitoba; Metoprolol; Oxides; Potassium; Tachycardia, Ventricular	2011

Article

Year

Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia.

The journal of the Royal College of Physicians of Edinburgh, 2011, Volume: 41, Issue:2

Topics: Adult; Anti-Arrhythmia Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Electrocardiography; Female; Humans; Leukemia, Promyelocytic, Acute; Magnesium; Manitoba; Metoprolol; Oxides; Potassium; Tachycardia, Ventricular

2011